vs
Getty图片控股（GETY）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Getty图片控股的季度营收约是Orthofix Medical Inc.的1.3倍（$282.3M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -32.2%，领先31.2%），Getty图片控股同比增速更快（14.1% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $7.7M），过去两年Getty图片控股的营收复合增速更高（12.7% vs 8.0%）
盖蒂图片控股是全球知名的视觉素材服务商，面向创意从业者、媒体机构与企业客户，提供正版商用图库、编辑类摄影、视频及音乐素材，旗下素材库规模超过4.77亿件，是全球视觉内容行业的龙头供应商之一。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
GETY vs OFIX — 直观对比
营收规模更大
GETY
是对方的1.3倍
$219.9M
营收增速更快
GETY
高出12.2%
2.0%
净利率更高
OFIX
高出31.2%
-32.2%
自由现金流更多
OFIX
多$9.1M
$7.7M
两年增速更快
GETY
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $282.3M | $219.9M |
| 净利润 | $-90.9M | $-2.2M |
| 毛利率 | 74.8% | 71.1% |
| 营业利润率 | -8.5% | 0.2% |
| 净利率 | -32.2% | -1.0% |
| 营收同比 | 14.1% | 2.0% |
| 净利润同比 | -467.6% | 92.4% |
| 每股收益（稀释后） | $-0.22 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GETYOFIX
| Q4 25 | $282.3M | $219.9M | ||
| Q3 25 | $240.0M | $205.6M | ||
| Q2 25 | $234.9M | $203.1M | ||
| Q1 25 | $224.1M | $193.6M | ||
| Q4 24 | $247.3M | $215.7M | ||
| Q3 24 | $240.5M | $196.6M | ||
| Q2 24 | $229.1M | $198.6M | ||
| Q1 24 | $222.3M | $188.6M |
净利润GETYOFIX
| Q4 25 | $-90.9M | $-2.2M | ||
| Q3 25 | $21.6M | $-22.8M | ||
| Q2 25 | $-34.4M | $-14.1M | ||
| Q1 25 | $-102.6M | $-53.1M | ||
| Q4 24 | $24.7M | $-29.1M | ||
| Q3 24 | $-2.5M | $-27.4M | ||
| Q2 24 | $3.7M | $-33.4M | ||
| Q1 24 | $13.6M | $-36.0M |
毛利率GETYOFIX
| Q4 25 | 74.8% | 71.1% | ||
| Q3 25 | 73.2% | 72.2% | ||
| Q2 25 | 72.1% | 68.7% | ||
| Q1 25 | 73.1% | 62.8% | ||
| Q4 24 | 73.5% | 69.0% | ||
| Q3 24 | 73.4% | 68.7% | ||
| Q2 24 | 72.5% | 67.8% | ||
| Q1 24 | 72.9% | 67.5% |
营业利润率GETYOFIX
| Q4 25 | -8.5% | 0.2% | ||
| Q3 25 | 18.8% | -8.3% | ||
| Q2 25 | 15.1% | -7.9% | ||
| Q1 25 | 12.2% | -25.2% | ||
| Q4 24 | 14.5% | -5.3% | ||
| Q3 24 | 23.9% | -9.6% | ||
| Q2 24 | 20.3% | -12.5% | ||
| Q1 24 | 18.5% | -15.6% |
净利率GETYOFIX
| Q4 25 | -32.2% | -1.0% | ||
| Q3 25 | 9.0% | -11.1% | ||
| Q2 25 | -14.6% | -6.9% | ||
| Q1 25 | -45.8% | -27.4% | ||
| Q4 24 | 10.0% | -13.5% | ||
| Q3 24 | -1.1% | -13.9% | ||
| Q2 24 | 1.6% | -16.8% | ||
| Q1 24 | 6.1% | -19.1% |
每股收益（稀释后）GETYOFIX
| Q4 25 | $-0.22 | $-0.05 | ||
| Q3 25 | $0.05 | $-0.57 | ||
| Q2 25 | $-0.08 | $-0.36 | ||
| Q1 25 | $-0.25 | $-1.35 | ||
| Q4 24 | $0.07 | $-0.76 | ||
| Q3 24 | $-0.01 | $-0.71 | ||
| Q2 24 | $0.01 | $-0.88 | ||
| Q1 24 | $0.03 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.2M | $82.0M |
| 总债务越低越好 | $1.3B | — |
| 股东权益账面价值 | $552.5M | $450.0M |
| 总资产 | $3.2B | $850.6M |
| 负债/权益比越低杠杆越低 | 2.30× | — |
8季度趋势，按日历期对齐
现金及短期投资GETYOFIX
| Q4 25 | $90.2M | $82.0M | ||
| Q3 25 | $109.5M | $62.9M | ||
| Q2 25 | $110.3M | $65.6M | ||
| Q1 25 | $114.6M | $58.0M | ||
| Q4 24 | $121.2M | $83.2M | ||
| Q3 24 | $109.9M | $30.1M | ||
| Q2 24 | $121.7M | $26.4M | ||
| Q1 24 | $134.2M | $27.0M |
总债务GETYOFIX
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $157.2M | ||
| Q2 25 | $1.3B | $157.0M | ||
| Q1 25 | $1.3B | $156.9M | ||
| Q4 24 | $1.3B | $157.0M | ||
| Q3 24 | $1.3B | $118.5M | ||
| Q2 24 | $1.3B | $118.0M | ||
| Q1 24 | $1.4B | $118.2M |
股东权益GETYOFIX
| Q4 25 | $552.5M | $450.0M | ||
| Q3 25 | $634.6M | $442.5M | ||
| Q2 25 | $611.2M | $458.3M | ||
| Q1 25 | $593.0M | $458.3M | ||
| Q4 24 | $670.2M | $503.1M | ||
| Q3 24 | $683.4M | $525.9M | ||
| Q2 24 | $654.0M | $546.0M | ||
| Q1 24 | $640.8M | $570.3M |
总资产GETYOFIX
| Q4 25 | $3.2B | $850.6M | ||
| Q3 25 | $2.6B | $832.6M | ||
| Q2 25 | $2.6B | $837.2M | ||
| Q1 25 | $2.6B | $823.1M | ||
| Q4 24 | $2.6B | $893.3M | ||
| Q3 24 | $2.6B | $867.9M | ||
| Q2 24 | $2.6B | $882.0M | ||
| Q1 24 | $2.6B | $906.0M |
负债/权益比GETYOFIX
| Q4 25 | 2.30× | — | ||
| Q3 25 | 2.11× | 0.36× | ||
| Q2 25 | 2.19× | 0.34× | ||
| Q1 25 | 2.21× | 0.34× | ||
| Q4 24 | 1.96× | 0.31× | ||
| Q3 24 | 1.97× | 0.23× | ||
| Q2 24 | 2.06× | 0.22× | ||
| Q1 24 | 2.16× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.6M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $7.7M | $16.8M |
| 自由现金流率自由现金流/营收 | 2.7% | 7.6% |
| 资本支出强度资本支出/营收 | 4.6% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.7M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流GETYOFIX
| Q4 25 | $20.6M | $27.7M | ||
| Q3 25 | $22.6M | $12.4M | ||
| Q2 25 | $6.5M | $11.6M | ||
| Q1 25 | $15.4M | $-18.4M | ||
| Q4 24 | $39.7M | $23.7M | ||
| Q3 24 | $10.7M | $11.7M | ||
| Q2 24 | $46.4M | $9.0M | ||
| Q1 24 | $21.5M | $-18.6M |
自由现金流GETYOFIX
| Q4 25 | $7.7M | $16.8M | ||
| Q3 25 | $7.9M | $2.5M | ||
| Q2 25 | $-9.6M | $4.5M | ||
| Q1 25 | $-322.0K | $-25.1M | ||
| Q4 24 | $24.6M | $15.2M | ||
| Q3 24 | $-1.8M | $6.3M | ||
| Q2 24 | $31.1M | $-360.0K | ||
| Q1 24 | $7.1M | $-29.1M |
自由现金流率GETYOFIX
| Q4 25 | 2.7% | 7.6% | ||
| Q3 25 | 3.3% | 1.2% | ||
| Q2 25 | -4.1% | 2.2% | ||
| Q1 25 | -0.1% | -13.0% | ||
| Q4 24 | 9.9% | 7.0% | ||
| Q3 24 | -0.8% | 3.2% | ||
| Q2 24 | 13.6% | -0.2% | ||
| Q1 24 | 3.2% | -15.4% |
资本支出强度GETYOFIX
| Q4 25 | 4.6% | 4.9% | ||
| Q3 25 | 6.1% | 4.8% | ||
| Q2 25 | 6.9% | 3.5% | ||
| Q1 25 | 7.0% | 3.5% | ||
| Q4 24 | 6.1% | 4.0% | ||
| Q3 24 | 5.2% | 2.7% | ||
| Q2 24 | 6.7% | 4.7% | ||
| Q1 24 | 6.5% | 5.6% |
现金转化率GETYOFIX
| Q4 25 | — | — | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.61× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.59× | — | ||
| Q1 24 | 1.58× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
